antibody
Showing 9976 - 10000 of >10,000
SARS-CoV-2 Infection Trial in Chicago (Vitamin D3)
Recruiting
- SARS-CoV-2 Infection
- Vitamin D3
-
Chicago, Illinois
- +1 more
Apr 26, 2021
Head and Neck Squamous Cell Carcinoma, Margin Assessment Trial in Groningen (Cetuximab-IRDye800CW)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Margin Assessment
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 30, 2021
Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,
Withdrawn
- Epstein-Barr Virus Positive
- +6 more
- Durvalumab
- Epacadostat
- (no location specified)
Oct 22, 2020
Clostridium Difficile Infection Trial (MK-6072, MK-3415A, Placebo)
Completed
- Clostridium Difficile Infection
- MK-6072
- +3 more
- (no location specified)
Aug 6, 2018
Covid19 Trial (COVI-AMG, Placebo)
Withdrawn
- Covid19
- COVI-AMG
- Placebo
- (no location specified)
Feb 9, 2021
Metastatic NSCLC Trial in Shanghai (GB226, Fruquintinib)
Recruiting
- Metastatic Non-small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai chest hospital
Mar 2, 2021
Idiopathic Retroperitoneal Fibrosis Trial in Beijing (Tocilizumab, Glucocorticoids)
Recruiting
- Idiopathic Retroperitoneal Fibrosis
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 17, 2021
Peritoneal Carcinomatosis, Colorectal Cancer, Carcinoma Trial in Nijmegen (drug, radiation, procedure)
Unknown status
- Peritoneal Carcinomatosis
- +4 more
- Indium-111-DOTA-Labetuzumab-IRDye800CW injection
- +2 more
-
Nijmegen, NetherlandsRadboudumc
Sep 12, 2019
Colorectal Tumors, Colorectal Carcinoma, Colorectal Cancer Metastatic Trial in Spain (Panitumumab, Irinotecan, Folinic acid)
Completed
- Colorectal Neoplasms
- +3 more
- Panitumumab
- +3 more
-
L'Hospitalet de Llobregat, Barcelona, Spain
- +11 more
Jun 18, 2021
Paediatric Inflammatory Multisystem Syndrome During COVID-19
Completed
- Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2
-
Chelmsford, Essex, United Kingdom
- +5 more
Feb 8, 2022
Pain, Chronic, Opioid Dependence, Opioid Use Trial in New York (Root.Health Dietary Supplement)
Enrolling by invitation
- Pain, Chronic
- +3 more
- Root.Health Dietary Supplement
-
New York, New YorkHudson Medical
Jun 9, 2023
Complement 2: Blood Donations to Develop Vaccines Against
Active, not recruiting
- Complement Mediated Bacterial Killing in Healthy Adults
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Oct 19, 2020
Semen Analysis Parameters Following Pfizer's COVID-19 Vaccine
Recruiting
- Covid19
- Fertility Issues
- Sperm collection
-
Ramat Gan, IsraelSheba medical center
Feb 27, 2021
Hepatocellular Carcinoma Trial in Wuhan (TACE+Lenvatininb+Camrelizumab)
Recruiting
- Hepatocellular Carcinoma
- TACE+Lenvatininb+Camrelizumab
-
Wuhan, Hubei, ChinaWuhan Union Hospital
May 27, 2021
Immunological Characteristics of COVID-19 Patients
Recruiting
- Covid19
-
Golnik, SloveniaUniversity Clinic of Respiratory and Allergic Diseases Golnik
Dec 21, 2020
Gout Trial in Birmingham (Denosumab)
Completed
- Gout
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 22, 2021
Alzheimers Disease, Dementia, Alzheimers Disease, Familial Trial in Worldwide (Gantenerumab, Solanezumab, Matching Placebo
ICIS in Burn Patients Compared to Other Inflammatory Markers
Recruiting
- Infection, Bacterial
- +2 more
- Flow fluorescence cytometry
-
Prague, CzechiaUniversity Hospital Kralovske Vinohrady
May 27, 2021
VACcination of LIver Transplantation Candidates
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- Vaccine immunogenicity
-
Lyon, FranceService des maladies infectieuses et tropicales - Hôpital de la
Jun 22, 2020
Breast Cancer Trial in Brazil (Hu3S193)
Terminated
- Breast Cancer
- Hu3S193
-
Fortaleza, Ceará, Brazil
- +6 more
Oct 9, 2019
Hepatitis, Liver Diseases, Acute Hepatitis Trial in Spain
Not yet recruiting
- Hepatitis
- +4 more
-
Jerez De La Frontera, Cádiz, Spain
- +9 more
Sep 29, 2021
Testing for COVID-19 Infection in Asymptomatic Persons
Completed
- COVID-19 Infection
-
Heidelberg, Baden-Württemberg, GermanyGerman Cancer Research Center
Mar 28, 2022
Peripheral T Cell Lymphoma, Relapse/Recurrence Trial in Belgium, France (Lacutamab, Gemcitabine, Oxaliplatine)
Recruiting
- Peripheral T Cell Lymphoma
- Relapse/Recurrence
- Lacutamab
- +2 more
-
Antwerpen, Belgium
- +38 more
Dec 6, 2021